trial

Low and High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Resistant Auditory Hallucination in Schizophrenia

NCTId NCT02175251
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 33 (actual)
Sponsored by Assistance Publique - Hôpitaux de Paris
Primary completion 2017-07-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
33 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2014-02
Primary completion
2017-07-07
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
high frequency (20Hz)low frequency (1Hz)

Sponsors

Assistance Publique - Hôpitaux de ParisLead Sponsor

Investigators

1
Caroline DUBERTRET, PU-PHStudy Director

Sites

1 total
Colombes, France

Facts & assertions

4 sourced
Enrollment
33
Phase
NA
Primary Completion Date
2017-07-07
Status
COMPLETED
relationships
The graph out of here
drug
high frequency (20Hz)
drug
low frequency (1Hz)
drug
lead_sponsor
Assistance Publique - Hôpitaux de Paris
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Caroline DUBERTRET, PU-PH
person